You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH)直線拉昇一度逼近漲停 稱為吉利德提供多個品種的CDMO服務
格隆匯 02-04 10:49
格隆匯2月4日丨九洲藥業(603456.SH)出現一波直線拉昇走勢,一度逼近漲停,現報17.68元,漲4.37%,暫成交2.54億元,最新總市值142億元。最新消息,九洲藥業在互動平台上表示,九洲藥業與吉利德於2011年開始合作,是公司戰略合作伙伴,公司已為其提供多個品種的CDMO服務,雙方合作緊密。美國吉利德在研藥物雷德西韋在國內受到關注。據此前公開文獻顯示,美國一位新型冠狀病毒患者使用該藥物後,病情得到有效好轉。因此,在國內抗擊新型冠狀病毒感染的肺炎疫情的戰鬥中,雷德西韋被寄予厚望,成為目前最受關注的治療“新冠肺炎”的藥物。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account